Research ExplorerScientific StaffJens Weidmann Publications

Jens Weidmann

graph of relations
Affiliations
1 - 8 out of 8Page size: 50

Publications

  1. 2024

  2. 74/m mit starken Schmerzen bei bekanntem metastasiertem Prostatakarzinom: Vorbereitung auf die Facharztprüfung. Fall 47

    Oechsle, K., Schieferdecker, A., Coym, A. & Weidmann, J., 04.2024, In: ONKOLOGIE-GER. 30, p. 329–334 8 p.

    Research output: SCORING: Contribution to journal › Training articles › Education

  3. 2023

  4. Praxismaterial: Angehörigen-Mitbetreuung "aus der Distanz". Möglichkeiten und Erfahrungen.

    Oechsle, K., Theißen, T., Gebert, T., Schieferdecker, A., Weidmann, J. & Ullrich, A., 2023, In: Praxis Palliative Care. 60, p. 1-11

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Transfer

  5. 2018

  6. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas

    Fiedler, W., Cresta, S., Schulze-Bergkamen, H., De Dosso, S., Weidmann, J., Tessari, A., Baumeister, H., Danielczyk, A., Dietrich, B., Goletz, S., Zurlo, A., Salzberg, M., Sessa, C. & Gianni, L., 2018, In: ESMO OPEN. 3, 2, p. e000303

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours

    Fiedler, W., Stoeger, H., Perotti, A., Gastl, G., Weidmann, J., Dietrich, B., Baumeister, H., Danielczyk, A., Goletz, S., Salzberg, M. & De Dosso, S., 2018, In: ESMO OPEN. 3, 4, p. e000381

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2017

  9. Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer

    Dulz, S., Asselborn, N. H., Dieckmann, K-P., Matthies, C., Wagner, W., Weidmann, J., Seidel, C., Oing, C., Berger, L. A., Alsdorf, W., Mankichian, B., Meyer, C., Vetterlein, M. W., Gild, P., Ludwig, T. A., Soave, A., Schriefer, P., Becker, A., Ahyai, S. A., Oechsle, K., Bokemeyer, C., Wagenfeld, L., Fisch, M., Hartmann, M., Chun, F. K-H. & Kluth, L. A., 07.2017, In: J CANCER RES CLIN. 143, 7, p. 1319-1325

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. 2016

  11. A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas

    Fiedler, W., DeDosso, S., Cresta, S., Weidmann, J., Tessari, A., Salzberg, M., Dietrich, B., Baumeister, H., Goletz, S., Gianni, L. & Sessa, C., 07.06.2016, In: EUR J CANCER. 63, p. 55-63 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. 2015

  13. Targeting the Gremlin-VEGFR2 axis - a promising strategy for multiple diseases?

    Erdmann, R., Ozden, C., Weidmann, J. & Schultze, A., 08.2015, In: J PATHOL. 236, 4, p. 403-6 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2014

  15. Akute myeloische Leukämie –bestmögliche Behandlung.

    Fiedler, W., Janning, M., Kebenko, M., Weidmann, J., Janjetovic, S. & Bokemeyer, C., 10.02.2014, In: Hamb Ärztebl. 68, p. 11-17 6 p.

    Research output: SCORING: Contribution to journal › Newspaper articles › Transfer